Nat Commun:中性粒细胞也能产生IL-6

2015-01-26 佚名 生物谷

近日,国际期刊Nature Communication在线发表了意大利科学家的一项最新研究成果,他们发现在人的中性粒细胞中,IL-6的染色质结构持续保持无活性的凝集状态。但当受到信号刺激,中性粒细胞中的IL-6基因位点的染色质能够发生重塑,从而启动IL-6表达和分泌。 关于人类中性粒细胞能否产生IL-6的问题一直存在争议,Maili Zimmermann等人利用分离纯化的人中性粒细胞发现,在无刺

近日,国际期刊Nature Communication在线发表了意大利科学家的一项最新研究成果,他们发现在人的中性粒细胞中,IL-6的染色质结构持续保持无活性的凝集状态。但当受到信号刺激,中性粒细胞中的IL-6基因位点的染色质能够发生重塑,从而启动IL-6表达和分泌。

关于人类中性粒细胞能否产生IL-6的问题一直存在争议,Maili Zimmermann等人利用分离纯化的人中性粒细胞发现,在无刺激情况下,IL-6基因位点的染色质结构呈凝集状态,当给与TLR8配体或TLR4配体刺激时,在IL-6转录起始位点上游约14kb位置存在的一个潜在增强子首先被诱导,而后影响了IL-6的基因表达。除此之外,IL-6的表达还受到内源性TNF-a的刺激,TNF-a能够促进共激活因子 IκBζ的合成,同时持续募集C/EBPβ并维持了IL-6基因调控区域的组蛋白乙酰化修饰。

综上所述,该文章利用分离纯化的中性粒细胞发现在受到刺激的情况下,人类中性粒细胞也能产生分泌IL-6,对于人中性粒细胞能否产生IL-6的争议提供了一个确实的实验证据。同时通过实验证明了中性粒细胞启动IL-6合成这一过程中,IL-6基因位点的染色质所发生的变化,说明染色质重塑以及细胞外信号刺激对中性粒细胞合成IL-6都是非常必要的。

原始出处

Zimmermann M1, Aguilera FB1, Castellucci M1, Rossato M1, Costa S1, Lunardi C2, Ostuni R3, Girolomoni G4, Natoli G3, Bazzoni F1, Tamassia N1, Cassatella MA1.Chromatin remodelling and autocrine TNFα are required for optimal interleukin-6 expression in activated human neutrophils.Nat Commun. 2015 Jan 23;

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1880469, encodeId=a3c81880469af, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jan 01 23:18:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086758, encodeId=1f002086e58f6, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Dec 13 08:18:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273746, encodeId=123c12e374611, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed Jan 28 00:18:00 CST 2015, time=2015-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296600, encodeId=ae4c1296600e9, content=<a href='/topic/show?id=29c82219e47' target=_blank style='color:#2F92EE;'>#中性粒细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22197, encryptionId=29c82219e47, topicName=中性粒细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Wed Jan 28 00:18:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]
    2016-01-01 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1880469, encodeId=a3c81880469af, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jan 01 23:18:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086758, encodeId=1f002086e58f6, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Dec 13 08:18:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273746, encodeId=123c12e374611, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed Jan 28 00:18:00 CST 2015, time=2015-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296600, encodeId=ae4c1296600e9, content=<a href='/topic/show?id=29c82219e47' target=_blank style='color:#2F92EE;'>#中性粒细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22197, encryptionId=29c82219e47, topicName=中性粒细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Wed Jan 28 00:18:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]
    2015-12-13 liuli5079
  3. [GetPortalCommentsPageByObjectIdResponse(id=1880469, encodeId=a3c81880469af, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jan 01 23:18:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086758, encodeId=1f002086e58f6, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Dec 13 08:18:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273746, encodeId=123c12e374611, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed Jan 28 00:18:00 CST 2015, time=2015-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296600, encodeId=ae4c1296600e9, content=<a href='/topic/show?id=29c82219e47' target=_blank style='color:#2F92EE;'>#中性粒细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22197, encryptionId=29c82219e47, topicName=中性粒细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Wed Jan 28 00:18:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]
    2015-01-28 kzlchina
  4. [GetPortalCommentsPageByObjectIdResponse(id=1880469, encodeId=a3c81880469af, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Jan 01 23:18:00 CST 2016, time=2016-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086758, encodeId=1f002086e58f6, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Dec 13 08:18:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273746, encodeId=123c12e374611, content=<a href='/topic/show?id=fae896e7ea' target=_blank style='color:#2F92EE;'>#IL-6#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9677, encryptionId=fae896e7ea, topicName=IL-6)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed Jan 28 00:18:00 CST 2015, time=2015-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296600, encodeId=ae4c1296600e9, content=<a href='/topic/show?id=29c82219e47' target=_blank style='color:#2F92EE;'>#中性粒细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22197, encryptionId=29c82219e47, topicName=中性粒细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Wed Jan 28 00:18:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

相关资讯

Oncogene:肿瘤细胞招募中性粒细胞驱动肺转移

肾细胞癌(renal cell carcinoma)是成年人原发性肾肿瘤中最常见的类型,占肾肿瘤的70~80%,占肾恶性肿瘤的90%。多见于60岁左右的人群,男性多于女性。初诊时肿瘤限于肾内的患者,术后五年生存率可达70%以上,但侵及肾静脉或扩散至肾周围脂肪组织的患者,五年生存率仅5~20%。 肾细胞癌(RCC)定向转移至肺组织的具体机制至今仍然知之甚少。为了研究分析转移过程中的具体分子机制,L

NEJM:基因检测有助于白血病靶向治疗

  《新英格兰医学杂志》5月8日在线发表的一项研究显示,集落刺激因子3(CSF3R)基因的致癌基因突变是慢性中性粒细胞白血病(CNL)和不典型慢性髓系白血病(CML)的决定性分子异常。检测这些突变不仅有助于诊断这两种罕见疾病,而且有助于评估以中性粒细胞增多为特征的病因不明的其他疾病。此外,基因检测还有助于改进骨髓增殖性肿瘤的分子分类。   在这项研究中,波特兰俄勒冈健康与科学大学血液与肿瘤系的J

Hepatology:CXCL5介导中性粒细胞浸润促进肝癌转移

趋化因子是能使细胞发生趋化运动的小分子细胞因子,分子量多在8-14kDa之间。趋化因子与趋化因子受体结合后传递多种细胞信息。CXCL5是一个小分子类型的分泌蛋白,属于趋型趋化因子家族成员。近来,CXCL5与癌症发生发展的相关证据已经有很多。 最近,为了研究CXCL5在肝细胞癌的生长、侵袭和预后中的作用,研究人员研究了具有不同转移性能的人肝癌细胞系以及919例肝癌患者中CXCL5的mRNA和蛋白水